Literature DB >> 24803376

Molecular and virological evidence of viral activation from chromosomally integrated human herpesvirus 6A in a patient with X-linked severe combined immunodeficiency.

Akifumi Endo1, Ken Watanabe2, Tamae Ohye3, Kyoko Suzuki4, Tomoyo Matsubara4, Norio Shimizu2, Hiroki Kurahashi3, Tetsushi Yoshikawa5, Harutaka Katano6, Naoki Inoue7, Kohsuke Imai8, Masatoshi Takagi8, Tomohiro Morio8, Shuki Mizutani8.   

Abstract

It has been unclear whether chromosomally integrated human herpesvirus 6 (ciHHV-6) can be activated with pathogenic effects on the human body. We present molecular and virological evidence of ciHHV-6A activation in a patient with X-linked severe combined immunodeficiency. These findings have significant implications for the management of patients with ciHHV-6.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HHV-6; X-SCID; ciHHV-6; hemophagocytic syndrome; thrombotic microangiopathy

Mesh:

Substances:

Year:  2014        PMID: 24803376     DOI: 10.1093/cid/ciu323

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  44 in total

1.  Transmission of chromosomally integrated human herpes virus-6A via haploidentical stem cell transplantation poses a risk for virus reactivation and associated complications.

Authors:  Lena Oevermann; Cosima Zimmermann; Sebastian Voigt; Annette Künkele; Stephan Lobitz; Angelika Eggert; Johannes H Schulte; Benedikt B Kaufer; Hedwig E Deubzer
Journal:  Bone Marrow Transplant       Date:  2019-04-15       Impact factor: 5.483

2.  Possible reactivation of chromosomally integrated human herpesvirus 6 after treatment with histone deacetylase inhibitor.

Authors:  Ioannis Politikos; Malgorzata McMasters; Christine Bryke; David Avigan; Vassiliki A Boussiotis
Journal:  Blood Adv       Date:  2018-06-26

3.  Prevalence of chromosomally integrated human herpesvirus 6 in patients with human herpesvirus 6-central nervous system dysfunction.

Authors:  Joshua A Hill; Ruth Hall Sedlak; Danielle M Zerr; Meei-Li Huang; Cecilia Yeung; David Myerson; Keith R Jerome; Michael J Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2014-09-22       Impact factor: 5.742

4.  Human herpesvirus 6 in transplant recipients: an update on diagnostic and treatment strategies.

Authors:  Joshua A Hill
Journal:  Curr Opin Infect Dis       Date:  2019-12       Impact factor: 4.915

5.  Efficient identification of inherited chromosomally integrated human herpesvirus 6 using specimen pooling.

Authors:  Joshua A Hill; Ruth HallSedlak; Amalia Magaret; Meei-Li Huang; Danielle M Zerr; Keith R Jerome; Michael Boeckh
Journal:  J Clin Virol       Date:  2016-02-20       Impact factor: 3.168

Review 6.  Human inborn errors of immunity to herpes viruses.

Authors:  Emmanuelle Jouanguy; Vivien Béziat; Trine H Mogensen; Jean-Laurent Casanova; Stuart G Tangye; Shen-Ying Zhang
Journal:  Curr Opin Immunol       Date:  2020-01-31       Impact factor: 7.486

7.  Cell Culture Systems To Study Human Herpesvirus 6A/B Chromosomal Integration.

Authors:  Annie Gravel; Isabelle Dubuc; Nina Wallaschek; Shella Gilbert-Girard; Vanessa Collin; Ruth Hall-Sedlak; Keith R Jerome; Yasuko Mori; Julie Carbonneau; Guy Boivin; Benedikt B Kaufer; Louis Flamand
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

8.  Stabilization of Telomere G-Quadruplexes Interferes with Human Herpesvirus 6A Chromosomal Integration.

Authors:  Shella Gilbert-Girard; Annie Gravel; Sara Artusi; Sara N Richter; Nina Wallaschek; Benedikt B Kaufer; Louis Flamand
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

Review 9.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 10.  Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know.

Authors:  M Ogata; T Fukuda; T Teshima
Journal:  Bone Marrow Transplant       Date:  2015-04-27       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.